Iovance Biotherapeutics (IOVA) EBIT (2009 - 2026)
Iovance Biotherapeutics (IOVA) reported EBIT of -$51.91 million for Q2 2026, compared with -$113.77 million a year earlier.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) EBIT (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Iovance Biotherapeutics' EBIT came in at -$301.31 million; for FY2025, it came in at -$403.36 million.
- By year, EBIT came in at -$395.28 million in FY2024, -$460.56 million in FY2023, -$398.88 million in FY2022 and -$342.7 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EBIT since Q3 2019.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$81.04 million (Q1 2026), -$73.46 million (Q4 2025) and -$94.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | -23.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -23.97 Mn |
| Jun 30, 2026 | -51.91 Mn |
| Mar 31, 2026 | -81.04 Mn |
| Dec 31, 2025 | -73.46 Mn |
| Sep 30, 2025 | -94.90 Mn |
| Jun 30, 2025 | -113.77 Mn |
| Mar 31, 2025 | -121.22 Mn |
| Dec 31, 2024 | -86.58 Mn |
| Sep 30, 2024 | -89.07 Mn |
| Jun 30, 2024 | -101.91 Mn |
| Mar 31, 2024 | -117.72 Mn |
| Dec 31, 2023 | -121.26 Mn |
| Sep 30, 2023 | -118.36 Mn |
| Jun 30, 2023 | -110.09 Mn |
| Mar 31, 2023 | -110.86 Mn |
| Dec 31, 2022 | -107.04 Mn |
| Sep 30, 2022 | -100.40 Mn |
| Jun 30, 2022 | -99.73 Mn |
| Mar 31, 2022 | -91.71 Mn |
| Dec 31, 2021 | -99.47 Mn |
API Access
Iovance Biotherapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();